Navigation Links
Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA(TM) in the U.S.
Date:8/26/2009

and Itnogen) is marketed across Europe by ProStrakan's own, in-house sales forces and is out-licensed by ProStrakan to Bayer Schering Pharma (BSP) in 147 countries, in many of which FORTESTA is planned to be promoted alongside Nebido((R)), which is Endo Pharmaceuticals' testosterone undecanoate product, or long-acting injectable, currently under regulatory review with the FDA in the United States.

About Hypogonadism

Hypogonadism, or low testosterone, is a common yet largely under-recognized and under-treated condition. An estimated 13.8 million American men have testosterone levels characterized as below normal (testosterone <300ng/dl). Yet despite this high prevalence, only about 9 percent of men with low testosterone are treated with testosterone replacement therapy.

About ProStrakan

ProStrakan Group plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets.

ProStrakan's head office is located in Galashiels, Scotland. The company's development capabilities are centered in Galashiels and Bedminster, New Jersey, USA. Sales and marketing of ProStrakan's portfolio of products are handled by commercial subsidiaries in the U.K., U.S., France, Germany, Spain and other EU countries. www.prostrakan.com

About Endo

Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, overactive bladder, prostate cancer and the early onset of puberty in children, or central precocious puberty (CPP). Its products include LIDODERM((R)), a topical patc
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Endo Pharmaceuticals Announces Cash Tender Offer for Any and All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes
2. Robin Leedy & Associates Wins Social Media Program For Union Springs Pharmaceuticals
3. Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
4. Raptor Pharmaceuticals Raises $5 Million
5. Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27, 2009
6. The Rossbacher Law Firm, Hagens Berman Sobol Shapiro LLP, Wilentz Goldman & Spitzer, P.A., Reed Smith LLP and Thompson Hine LLP, Announce the Proposed Settlement of a Class Action Lawsuit Concerning Estratest and Solvay Pharmaceuticals, Inc.
7. NovaBay Pharmaceuticals to Present New Pre-Clinical Data on Lead Anti-Infective Compound for use in Onychomycosis at the 2009 IDSA Annual Meeting
8. Warner Chilcott Acquires P&Gs Global Pharmaceuticals Business
9. Valeant Pharmaceuticals Announces Preliminary Results From Its Phase IIa Retigabine Study for the Treatment of Postherpetic Neuralgia (PHN)
10. Sound Pharmaceuticals Receives an Office of Naval Research Award for Its Hearing Loss Research and Development
11. Adamas Pharmaceuticals Raises $40 Million in Series D Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Australia (PRWEB) August 27, 2014 ... erratic climatic conditions and fluctuations in global supply and ... the past five years. The industry derives a large ... are subject to global market dynamics, with supply and ... Brazil and India. A strong Australian dollar for the ...
(Date:8/27/2014)... August 27, 2014 SCOTT Sports ... Park, Utah’s first indoor mountain bike and BMX park. ... park-style bikes in both adult and youth sizes for the ... operated a distribution warehouse in Ogden, Utah, recently moved its ... , “We are proud to be a partner with the ...
(Date:8/27/2014)... and a new UCLA study has shown this is definitely ... decisions about how to treat their prostate cancer. , UCLA ... disease have a much more difficult time making treatment decisions, ... quality of their care and their long-term outcomes. , The ... can use the findings to target men less likely to ...
(Date:8/27/2014)... who eat over 10 portions a week of tomatoes ... prostate cancer, new research suggests. , With 35,000 new ... deaths, prostate cancer is the second most common cancer ... countries, which some experts believe is linked to a ... dietary and lifestyle recommendations reduces risk of prostate cancer, ...
(Date:8/27/2014)... Bedros Keuilian is the founder of the fastest ... fitness boot camp marketing expert in the industry ... thing he knows very well is how to build a ... the fitness business. , In his new, hour-long webinar ... instructional guide on how fitness boot camp owners and personal ...
Breaking Medicine News(10 mins):Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:SCOTT Sports to Sponsor Wasatch Indoor Bike Park 2Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 2Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 3Health News:Fighting prostate cancer with a tomato-rich diet 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 3
... to clinical ... trials ... company,focused on developing web-based integrated clinical trials management,systems (CTMS), announced ... research organization (CRO) and ECG core,lab Spacelabs Healthcare Clinical Trial ...
... (CALBIA), a non-profit membership organization providing information, education, ... injury, together with the Scarlett Law Group ... traumatic brain injury , invite you to participate ... medical/legal conferences dealing with traumatic brain injury: State ...
... Global: Contemporary Pharmacovigilance and Medical Product Risk Management Strategies (December ... ... Horsham, PA (Vocus) October 28, 2008 -- The field of ... clinical trial safety and post-marketing pharmacovigilance becoming ever more critical ...
... "Protective Life Insurance Company," to their portfolio of available insurance ... ... October 28, 2008 -- TheHealthQuote continues to grow with the ... of top rated insurance companies - which currently spans over ...
... their prolonged seizures with the sedative propofol may be ... research presented at CHEST 2008, the 74th annual international ... (ACCP), shows that the use of propofol as an ... prolonged seizures that do not respond to initial treatment, ...
... 2008 Childhood obesity can lead to type 2 ... children and youth are likely to be obese as ... stroke and incur higher healthcare costs. In an article ... American Journal of Preventive Medicine, researchers report that ...
Cached Medicine News:Health News:ECRFPlus Achieves Milestone Multimillion Dollar Enterprise Agreement With CRO and Launches e-CRF+(TM): a CTMS and EDC Web Platform With ECG Analysis and Cardiac Safety Module. 2Health News:ECRFPlus Achieves Milestone Multimillion Dollar Enterprise Agreement With CRO and Launches e-CRF+(TM): a CTMS and EDC Web Platform With ECG Analysis and Cardiac Safety Module. 3Health News:ECRFPlus Achieves Milestone Multimillion Dollar Enterprise Agreement With CRO and Launches e-CRF+(TM): a CTMS and EDC Web Platform With ECG Analysis and Cardiac Safety Module. 4Health News:California Brain Injury Association and Scarlett Law Group Conduct Medical/Legal Conference on Traumatic Brain Injury November 21 - 23rd, 2008 2Health News:California Brain Injury Association and Scarlett Law Group Conduct Medical/Legal Conference on Traumatic Brain Injury November 21 - 23rd, 2008 3Health News:DIA Conference to Explore Global Pharmacovigilance and Risk Management Strategies and Regultory Frameworks 2Health News:DIA Conference to Explore Global Pharmacovigilance and Risk Management Strategies and Regultory Frameworks 3Health News:Esteemed Medical and Life Insurance Provider Adds to Their List of Top-Rated Insurance Options 2Health News:Esteemed Medical and Life Insurance Provider Adds to Their List of Top-Rated Insurance Options 3Health News:Anti-seizure drug could be fatal 2Health News:Green neighborhoods may reduce childhood obesity 2
(Date:8/27/2014)... Aug. 27, 2014 Ambit Biosciences (Nasdaq: AMBI ... drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, ... Care Conference to be held at The New York Palace ... September 3-4, 2014. Alan Fuhrman , Ambit,s ... lead drug candidate, quizartinib, at 1:10 p.m. ET on Wednesday, ...
(Date:8/27/2014)... -- After the February 2014 launch of their new ... medical practices and management companies, Prime Clinical is reporting ... "The feedback has been great," says Director of ... of demos and new sign-ups is a reflection of ... of software features." Prime Clinical developed ...
(Date:8/27/2014)... 27, 2014  Zimmer Holdings, Inc. (NYSE and SIX: ... it will be participating in the Morgan Stanley 2014 ... New York, New York , on Tuesday, ... CEO of Zimmer, will be presenting at 9:10 a.m. ... of Biomet, will join Mr. Dvorak for the Q&A ...
Breaking Medicine Technology:Ambit Announces Participation At Baird 2014 Health Care Conference 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 3
... The optimal combination of performance ... New 4x5 mL swinging bucket rotor. ... 0.2 ml to 8.3 ml, with ... drive, very quiet operation, rotor imbalance ...
... Optima MAX has the highest g-force ... takes more than force. Optima MAX combines ... to achieve benchtop performance that's worlds apart ... features, superior design, and enhanced efficiency, Optima ...
... Capable of generating 694,000 x ... 90,000 rpm, Beckman Coulter's Optima ... perform more separations in less ... operates with a broad range ...
... L-XP ultracentrifuge is designed to play ... process if research involves proteomics, cytomics ... on-board computer, enhanced firmware, powerful Optima ... screen, Optima L-XP delivers superior functionality, ...
Medicine Products: